Next Generation Sequencing allows for testing and typing of entire genes of the HLA region. A better and comprehensive sequence assessment can be achieved by the inclusion of full gene sequences of all the common alleles at a given locus. The common alleles of DRB5 are under-characterized with the full exon-intron sequence of two alleles available. In the present study the DRB5 genes from 18 subjects alleles were cloned and sequenced; haplotype analysis showed that 17 of them had a single copy of DRB5 and one consanguineous subject was homozygous at all HLA loci. Methodological approaches including robust and efficient long-range PCR amplification, molecular cloning, nucleotide sequencing and de novo sequence assembly were combined to characterize DRB5 alleles. DRB5 sequences covering from 5'UTR to the end of intron 5 were obtained for DRB5*01:01, 01:02 and 02:02; partial coverage including a segment spanning exon 2 to exon 6 was obtained for DRB5*01:03, 01:08N and 02:03. Phylogenetic analysis of the generated sequences showed that the DRB5 alleles group together and have distinctive differences with other DRB loci. Novel intron variants of DRB5*01:01:01, 01:02 and 02:02 were identified. The newly characterized DRB5 intron variants of each DRB5 allele were found in subjects harboring distinct associations with alleles of DRB1, B and/or ethnicity. The new information provided by this study provides reference sequences for HLA typing methodologies. Extending sequence coverage may lead to identify the disease susceptibility factors of DRB5 containing haplotypes while the unexpected intron variations may shed light on understanding of the evolution of the DRB region.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622178PMC
http://dx.doi.org/10.1016/j.humimm.2019.04.001DOI Listing

Publication Analysis

Top Keywords

drb5 alleles
12
drb5
10
alleles
8
common alleles
8
alleles drb5
8
0102 0202
8
intron variants
8
sequence
5
complete nucleotide
4
nucleotide sequence
4

Similar Publications

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, responsible for Coronavirus Disease 2019 (COVID-19), exhibits a spectrum of clinical manifestations, ranging from asymptomatic to severe pulmonary dysfunction or death. The variability in COVID-19 severity has largely been attributed to the host's genetic characteristics, suggesting a polygenic genetic architecture, without significant strong evidence of sex-related genetic differences. In this Italian retrospective case-control study, we investigated the association between COVID-19 severity (severe vs.

View Article and Find Full Text PDF

HLA-DRB5*02:02:05 differs from HLA-DRB5*02:02:01 by one nucleotide substitution in codon 134 in exon 3.

View Article and Find Full Text PDF

HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study.

BMC Med

October 2024

Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China.

Article Synopsis
  • * In a study involving 47,550 cancer patients, researchers found specific protective and hazardous HLA alleles linked to SPC, with certain alleles reducing risk while others increased it, particularly in relation to organ-specific occurrences.
  • * The findings indicate that HLA alleles could act as biomarkers for SPC susceptibility, and that diet may influence risk, highlighting the need for personalized dietary recommendations based on HLA status.
View Article and Find Full Text PDF

Discovery of potential recombinant alleles HLA-DRB3*02:171 and HLA-DRB5*01:140.

HLA

September 2024

Transplant Laboratory South, Alberta Precision Laboratories, Calgary, Alberta, Canada.

Two novel alleles that appear to be generated from recombination between exons 2 and 3.

View Article and Find Full Text PDF

Molecular HLA typing techniques are currently undergoing a rapid evolution. While real-time PCR is established as the standard method in tissue typing laboratories regarding allocation of solid organs, next generation sequencing (NGS) for high-resolution HLA typing is becoming indispensable but is not yet suitable for deceased donors. By contrast, high-resolution typing is essential for stem cell transplantation and is increasingly required for questions relating to various disease associations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!